HCPCS code J9174: Docetaxel injection, beizray, per 1 mg2026 Medicare rate & RVUs in Illinois
Reports docetaxel supplied as Beizray for cancer treatment, with each HCPCS unit representing 1 mg of the drug furnished.
CMS doesn’t publish an office rate for J9174 in Illinois.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9174 covers
This code identifies docetaxel supplied as Beizray, an antineoplastic taxane used in chemotherapy regimens for cancers including breast, lung, prostate, and stomach cancer. It is typically furnished by oncology practices, hospital outpatient departments, and other clinicians administering cancer treatment. Docetaxel is given by intravenous infusion; this code identifies the drug, not the infusion service.
CMS assigns status E, excluding the code from the physician fee schedule. When Medicare covers the drug, payment is under another method; the HCPCS pricing method identifies it as a Part B drug generally priced using CMS quarterly Average Sales Price files. Coverage is left to the Medicare contractor's judgment. Report the quantity administered in 1 mg units: for example, 100 mg corresponds to 100 units. The administration service is reported separately when applicable.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9174 pays more and less in Illinois
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Chicago, IL | Unavailable | Unavailable |
| East St. Louis, IL | Unavailable | Unavailable |
| Rest of Illinois | Unavailable | Unavailable |
| Suburban Chicago, IL | Unavailable | Unavailable |
How the J9174 rate is calculated
Each of J9174’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9174
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9174
J9174 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9174
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9174 isn’t priced in this setting.
J9174 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9171Docetaxel injectionPer 1 mg
- J9171 is the general docetaxel injection code; J9174 identifies docetaxel supplied as Beizray.
- J9172Docetaxel injectionDocivyx, per 1 mg
- J9172 identifies Docivyx docetaxel in 1 mg units. J9174 is for Beizray docetaxel, also in 1 mg units.
- 96413Chemo IV infusionInitial drug, first hour
- 96413 reports chemotherapy infusion administration, not the docetaxel drug. J9174 identifies the drug quantity.
J9174 billing questions
How is J9174 different from J9172?
Both identify docetaxel in 1 mg units, but J9174 is specific to Beizray and J9172 identifies Docivyx. Select the code matching the product furnished.
How many units should be reported?
Each unit represents 1 mg of docetaxel. Convert the amount administered to milligrams and report that number of units.
Does J9174 include the infusion service?
No. J9174 identifies the drug; the chemotherapy administration service is a separate service when separately reportable.
How does Medicare price and cover J9174?
CMS excludes it from the physician fee schedule with status E. When covered, it is a Part B drug generally priced through CMS quarterly ASP files, and coverage is left to the Medicare contractor's judgment.
Is J9174 interchangeable with the general docetaxel code?
J9171 identifies docetaxel without the Beizray product designation. Use J9174 when Beizray is the product furnished.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9174 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist